User Tools

    To create and edit articles, please register and log-in

Main Menu : categories & index etc.

Main menu
Click categories to expand


A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing

This is an alphabetical index of all content pages.


Other categories

Utilities

Contact
Register
Sandbox

Also see

Importance Ratings
News
Legal
Donate/Sponsor
Curator's rationale
AI Policy



Twitter feed 𝕏



Feeds + s.e.o. etc.
rss / xml feed
sitemap file
A-Z listing (archived)


Indexed under : Medicine / Drugs

Wikenigma - an Encyclopedia of Unknowns Wikenigma - an Encyclopedia of the Unknown

Isotretinoin

Isotretinoin (13-cis-retinoic acid) is a medication primarily used to treat severe Acneplugin-autotooltip__plain plugin-autotooltip_bigAcne

Acne is an extremely common skin condition which mainly affects the adolescent population (currently estimated at over 90%).

Despite very intensive research over many decades, a detailed explanation of what triggers and maintains the condition is still lacking.
. It's also occasionally used to help prevent certain skin cancers such as squamous-cell carcinoma, and (rarely) in the treatment of some other cancers. It's sold under various brand names, including : Accutane, Roaccutane, Rizuderm and more than 120 others.

While isotretinoin is currently the most effective agent for patients with moderate-to-severe acne, the drug’s potential to induce human congenital abnormalities, and its wide range of adverse side-effects, is driving research to find replacements. This is hampered because :

“Isotretinoin's exact mechanism of action is unknown, but several studies have shown that isotretinoin induces apoptosis (programmatic cell death) in various cells in the body.”

Source : Wikipedia

At pharmacologic doses, isotretinoin inhibits sebaceous gland function and keratinization, but as noted above, its precise mechanism of action is unknown. Several studies have shown that isotretinoin induces apoptosis (programmatic cell death) in various cells in the body.


    Please share this page to help promote Wikenigma !

Dear reader : Do you have any suggestions for the site's content?

Ideas for new topics, and suggested additions / corrections for older ones, are always welcome.

If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !


Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.

( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)

Automatic Translation

You are currently viewing an auto-translated version of Wikenigma

Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.

Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.

Show another (random) article

Further resources :

DOKUWIKI IMPLEMENTATION DESIGN BY UNIV.ORG.UK DECEMBER 2023